Evidence map›Paper›PMID 39398276›Full record

ArticleFrontiers in molecular biosciences2024

HPLC for at-line reaction monitoring and purification improves yield and purity of tRNA.

Polona Megušar, Ewen D D Calder, Tina Vodopivec Seravalli, Sergeja Lebar, Louise J Walport, Rok Sekirnik

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Polona Megušar *Sartorius BIA Separations d.o.o., Ajdovščina, Slovenia.
Ewen D D Calder *Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London, United Kingdom.
Tina Vodopivec SeravalliSartorius BIA Separations d.o.o., Ajdovščina, Slovenia.
Sergeja LebarSartorius BIA Separations d.o.o., Ajdovščina, Slovenia.
Louise J WalportDepartment of Chemistry, Molecular Sciences Research Hub, Imperial College London, London, United Kingdom.
Rok SekirnikSartorius BIA Separations d.o.o., Ajdovščina, Slovenia.

Funding

Wellcome Trust CC2030
6 · The paper itself

Abstract

Engineered transfer RNA is an emerging therapeutic modality, particularly suited to treatment of diseases caused by genetic disorders based on premature termination codons, frameshifts, or missense mutations. It is also extensively used in reprogramming of

Indexed as

anion exchangechromatographyHPLCin vitro transcriptiontRNA

Identifiers

PMID39398276
PMCPMC11466894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.